Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s skepticism of mRNA vaccines has cost the company dearly.

Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting, following the 149th Annual Meeting of Shareholders, held in Osaka today.

Protagonist Therapeutics Inc. (NASDAQ:PTGX) is one of the best mid cap growth stocks to invest in now. Just as June began, ...

View the latest Takeda Pharmaceutical Co. Ltd. ADR (TAK) stock price, news, historical charts, analyst ratings and financial information from WSJ.

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, Inc. (Nasdaq: KROS ...

View today's Takeda Pharmaceutical Co., Ltd. stock price and latest 4502 news and analysis. Create real-time notifications to follow any changes in the live stock price.

New hires: Acadia Pharmaceuticals named Allyson McMillan-Youngblood as SVP of the rare disease franchise.. Indivior appointed Patrick Barry as its chief commercial officer.. Hillstar Bio appointed ...

NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass., June 01, 2025--Protagonist Therapeutics, Inc. ("Protagonist") (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announced detailed results from the ...

A high-level overview of Takeda Pharmaceutical Company Limited (TAK) stock. View (TAK) real-time stock price, chart, news, analysis, analyst reviews and more.

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announced detailed results from the Phase 3, randomized, placebo-controlled VERIFY study evaluating ...

Learn about the executive team and board of directors at Takeda Pharmaceutical Co Ltd (4502:XTKS) and review their bios and compensation over the latest fiscal years.

Stay up to date on how Takeda Pharmaceutical Co Ltd (TKPHF:PINX) stock has performed compared to similar stocks in the same industry on a daily, quarterly, and monthly basis.